Case Report
Published on 23 Oct 2023
Pembrolizumab combined with anlotinib improves therapeutic efficacy in pulmonary sarcomatoid carcinoma with TMB-H and PD-L1 expression: a case report and literature review
in Comparative Immunology
- 3,703 views
- 7 citations